Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -2 of 2
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
1/25/2008
 
First Published:
8/1/2002
1.
Phase II Study of D1/3-MAGE-3-His Fusion Protein With SB-AS02B Adjuvant in Patients With Stage IV Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
Not specified
NCI
SWOG-S0116
NCT00042783, S0116
Last Modified:
8/19/2008
 
First Published:
6/23/2004
2.
Phase II Randomized Study of Immunization With Vaccine Comprising D1/3-MAGE-3-His Fusion Protein and SB-AS02B Adjuvant Versus SB-AS15 Adjuvant in Patients With Unresectable Stage III or Stage IV M1a Cutaneous Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Other
EORTC-18031
EORTC-16032, GSK-249553/008, EUDRACT-2004-001937-40, NCT00086866
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute